For citation:

Blinov D.V. PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2014;7(1):40-45. (In Russ.)